D
Direct Flow Medical
Transcatheter heart valve technologies that improve patient outcomes while reducing patient complications
About Direct Flow Medical
Direct Flow Medical specializes in providing effective solutions for erectile dysfunction and benign prostatic hyperplasia through its flagship product, Tadalafil, sold under the brand name Cialis. The company operates in the pharmaceutical market, targeting adult men who experience these medical conditions. Direct Flow Medical's business model revolves around the sale of both branded and generic versions of Cialis, offering various dosages to meet different patient needs. Revenue is generated through direct sales to consumers via their online platform, as well as through partnerships with healthcare providers and pharmacies. The company emphasizes the long-lasting effects of its product, which can last up to 36 hours, and its ability to work independently of food intake, setting it apart from many other erectile dysfunction drugs.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Risk Management, Biotechnology, Cardiology and cardiovascular, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Direct Flow Medical is 150 monthly website visits, down 64.3% over the last three months. Direct Flow Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Direct Flow Medical in the Santa Rosa ecosystem
The Direct Flow Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- CPcapital partners
Series A6 investors entered at this stage
- EVEDF Ventures
VantagePoint Capital Partners
Spray Venture Partners
ePlanet Capital
Johnson & Johnson Development Corporation
New Leaf Venture Partners
Series B and later4 investors entered at this stage
Saints Capital- FPFoundation Medical Partners
PDL Biopharma
SV Health Investors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Direct Flow Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Direct Flow Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







